<ѻýҕl>Low-Dose 'Quadpill' Reduces High Blood Pressureѻýҕl> Significantly lower diastolic blood pressure at 12 weeks, U.S.-based study showed Nov 09, 2022
<ѻýҕl>Strong Showing for Novel BP-Lowering Drugs in Resistant Hypertensionѻýҕl> Aprocitentan targets the endothelin pathway, whereas baxdrostat blocks aldosterone production Nov 09, 2022
<ѻýҕl>Can Botox for the Heart Ward Off Afib After Cardiac Surgery?ѻýҕl> Epicardial botulinum toxin generally not better than placebo in the NOVA study Nov 09, 2022
<ѻýҕl>Precision Medicine Strategy Reduced Testing in Patients With Chest Painѻýҕl> Also reduced risk of composite endpoint of death, MI, and catheterization compared with usual care Nov 08, 2022
<ѻýҕl>Anticoagulation Again Flops for Outpatient COVID-19ѻýҕl> Largest-yet RCT shows no benefit for non-hospitalized symptomatic patients despite elevated risk Nov 08, 2022
<ѻýҕl>Upfront ECMO Disappoints for Cardiogenic Shockѻýҕl> High-cost procedure not yet justified as an early strategy Nov 07, 2022
<ѻýҕl>Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefitѻýҕl> Randomized trial shows advantages across heart failure spectrum Nov 07, 2022
<ѻýҕl>Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMIѻýҕl> BRIGHT-4 trial hands the drug a "clear, unambiguous win" against heparin Nov 07, 2022
<ѻýҕl>Early Invasive Strategy for Stable CAD Holds No Long-Term Survival Advantageѻýҕl> Extended follow-up of ISCHEMIA trial weighs in on mortality Nov 07, 2022
<ѻýҕl>Experts Agree Intravenous Iron Shows Promise for Heart Failure Patientsѻýҕl> While findings were not significant, the study was impacted by COVID lockdowns, researcher says Nov 07, 2022
<ѻýҕl>Study Refutes Heart Health Claims of Dietary Supplementsѻýҕl> LDL cholesterol reductions with cinnamon, garlic, and others not on par with statin Nov 06, 2022
<ѻýҕl>Decision-Support Tool Enhances Outcomes for Heart Failure Patients in the EDѻýҕl> Pathways for HF patients picked for early discharge versus admission Nov 06, 2022
<ѻýҕl>Definitive Answer on Steroids for Infant Heart Surgery Falls Shortѻýҕl> STRESS trial misses primary endpoint but secondary benefits are suggestive Nov 06, 2022
<ѻýҕl>Diuretics on Par in Head-to-Head Comparison for Hypertensionѻýҕl> But a surprise signal emerges for one group in pragmatic trial Nov 06, 2022
<ѻýҕl>Mixed Results With Pemafibrate in Patients With Type 2 Diabetesѻýҕl> No impact on CV events in PROMINENT; developer brings trial to an end Nov 06, 2022
<ѻýҕl>Furosemide Holds Up to Newer, Stronger Loop Diuretic During HF Hospitalizationѻýҕl> Preference for mainstay decongestant versus torsemide likely unchanged after TRANSFORM-HF study Nov 05, 2022
<ѻýҕl>Bentracimab on Point as Fast-Acting Ticagrelor Reversal Agentѻýҕl> "Immediate and sustained" benefit, interim REVERSE-IT analysis found Nov 17, 2021
<ѻýҕl>Oral Factor XIa Inhibitor Sets the Stage for a Safer Anticoagulantѻýҕl> Milvexian shows promise in preventing vein clots after total knee replacement surgery Nov 16, 2021
<ѻýҕl>Oral PCSK9 Inhibitor Slashed Cholesterolѻýҕl> Reductions of 65% observed in phase I trials Nov 16, 2021
<ѻýҕl>Potent Antiplatelet Not a Good Idea for Moderate COVID-19ѻýҕl> ACTIV-4a trial suggests harm for hospitalized patients outside the ICU Nov 16, 2021
<ѻýҕl>Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozinѻýҕl> EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
<ѻýҕl>Vascepa Succumbs as COVID Treatment in 'Underpowered' Trialѻýҕl> Purified fish oil didn't help SARS-CoV-2-positive outpatients Nov 15, 2021
<ѻýҕl>Aspirin Flops Again for Dementia Preventionѻýҕl> ASCEND trial sides with ASPREE, but can't rule out some potential benefit Nov 15, 2021
<ѻýҕl>Stem Cells Don't Prevent Acute Heart Failure Eventsѻýҕl> DREAM-HF trial does hold some positive signals, though Nov 15, 2021
<ѻýҕl>Some Good News for Curious Afib Patients Looking to Find Their Own Triggersѻýҕl> Presumed Afib triggers put to the test in n-of-1 studies Nov 14, 2021
<ѻýҕl>PALACS: A Win for Posterior Left Pericardiotomy for Post-Op Afibѻýҕl> Trial offers good news for patients getting coronary, aortic valve, and aortic surgeries Nov 14, 2021
<ѻýҕl>Two Anticoagulants -- When Used Correctly -- Similarly Protective Against Dementiaѻýҕl> GIRAF trial tested warfarin versus dabigatran in older Afib patients Nov 14, 2021
<ѻýҕl>Coffee Causes This One Arrhythmia, Trial Showsѻýҕl> Overall mixed results in the CRAVE randomized trial Nov 14, 2021
<ѻýҕl>Tricuspid Repair Boosts Mitral Valve Surgery Outcomesѻýҕl> Randomized trial supports combined surgery for moderate regurgitation Nov 13, 2021
<ѻýҕl>Delaying Surgery Hurts Patients With Silent Aortic Stenosisѻýҕl> Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
<ѻýҕl>Early CABG After Stopping Ticagrelor is Possible -- But is It Ready for Prime-Time?ѻýҕl> RAPID CABG shows non-inferority of shorter wait; expert advises caution for real-world practice Nov 13, 2021
<ѻýҕl>Antibiotics Slow Down Latent Rheumatic Heart Disease in Kidsѻýҕl> GOAL trial supports screening Nov 13, 2021
<ѻýҕl>COVID's Heart Complications Modest in Large Registryѻýҕl> Obese and minority groups at higher risk, though, analyses affirm Nov 18, 2020
<ѻýҕl>AHA: Highlighting Effective 'Real-World' Heart Tx Strategiesѻýҕl> Studies on overcoming GDMT underuse, improving self-care education, creating new settings for care delivery Nov 17, 2020
<ѻýҕl>Post-Surgery Monitoring Finds Afib in Discharged Patientsѻýҕl> About 20% of patients had episodes recorded on devices, study showed Nov 17, 2020
<ѻýҕl>Sotagliflozin Prevents Heart Events in Acute HF, Chronic Kidney Diseaseѻýҕl> Two trials show some tantalizing signals for HFpEF and stroke Nov 17, 2020
<ѻýҕl>Novel Screening Approach Promising for Silent CADѻýҕl> More than 40% of healthy Swedish participants still had subclinical coronary artery disease Nov 16, 2020
<ѻýҕl>VITAL-AF, mSToPS: Mixed Results in Afib Screeningѻýҕl> A signal that screening by continuous ECG monitoring leads to better outcomes Nov 16, 2020
<ѻýҕl>Skip Rhythm Drugs, Go Straight to Cryoablation for Afibѻýҕl> Two trials support shift into first-line strategy Nov 16, 2020
<ѻýҕl>ANGPTL3 Blocker Halves LDL in High-Risk Groupѻýҕl> Evinacumab worked in patients refractory to statins, PCSK9 inhibitors Nov 16, 2020